New York, NY, December 15, 2009 —
Small Bone Innovations, Inc. (SBi), a leading, privately held orthopedics
company focused exclusively on technologies and treatments for the small
bones & joints, announced the formation of a joint venture with
Khazanah Nasional Berhad (Khazanah) and Malaysian Technology Development
Corporation Sdn. Bhd. (MTDC). The joint venture, SBi Asia Pacific Sdn.
Bhd. (SBi APAC), is based in Kuala Lumpur, Malaysia.
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Brothers, LLC, (VB), a New York-based merchant banking firm that specializes in the musculoskeletal/orthopedic sector. VB created SBi as the first company to focus purely on small bones & joints. By integrating established companies and professionals in the field, SBi offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints.
Today, SBi has more than 140 employees at facilities in New York, NY, Morrisville, PA, and Bourg-en-Bresse, France, among other locations worldwide.
For more information on SBi, please visit: www.totalsmallbone.com
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated exclusively to the musculoskeletal/orthopedics sector of the health care industry. As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector.
VB’s mission is to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on “life changing” musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships, and significant financial expertise in the musculoskeletal/orthopedic sector.
The Viscogliosi brothers have pioneered more than 170 financial, strategic
and management initiatives for companies in the musculoskeletal/orthopedic
sector, from start-up, seed and development stage all the way to exit.
These initiatives have helped people live better lives through the orthopedic
and spinal products developed, marketed and sold by the companies VB
has assisted in developing and financing.
This press release contains forward-looking statements as defined in
the U.S. Private Securities Litigation Reform Act of 1995. Readers are
cautioned not to place undue reliance on these forward-looking statements.
Actual results may differ materially from those indicated by these forward-looking
statements as a result of risks and uncertainties impacting SBi’s
business including increased competition; the ability of SBi to expand
its operations and to attract and retain qualified professionals; technological
obsolescence; general economic conditions; and other risks.